Cannabis Therapy Firm: CBD Jab Reduces Pain In Arthritic Dogs 

An Israeli company that develops cannabis-based therapeutics says its CBD injections have proven effective in providing pain relief for dogs with naturally occurring osteoarthritis. 

According to InnoCan Pharma, a long-term treatment plan consistently demonstrated the LPT-CBD injection’s efficacy in pain reduction and improved mobility, with the effects lasting for several weeks after each treatment. 

This, the company says, demonstrates that LPT-CBD can be a viable treatment option for managing chronic pain and enhancing the quality of life in animals.

Two dogs suffering from osteoarthritis were treated for two years or more with LPT-CBD after failing to respond to non-steroidal anti-inflammatory drugs and oral CBD. Both animals showed noticeable pain relief, substantially improved mobility and obvious increased well-being. 

“We are thrilled with these findings, which highlight the long-lasting effects of repeated administration of LPT-CBD to treat chronic pain,” said InnoCan CSO Prof. Chezy Barenholz. 

“These results support the potential of LPT-CBD as a monthly treatment for chronic pain conditions, providing sustained relief. They position LPT-CBD as a breakthrough solution for managing chronic pain in animals and, by extension, human patients,” he said.

“This compassionate therapy has demonstrated significant efficacy in companion dogs and reinforces our commitment to advance FDA’s Center for Veterinary Medicine (CVM) approval of LPT-CBD for the treatment of chronic pain in dogs,” said Dr. Eyal Kalo, InnoCan’s director of R&D.